Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | CA3 | P07451 | 1/20 | 0.45 |
| ▸ | CA4 | P22748 | 1/20 | 0.45 |
| ▸ | CA6 | P23280 | 1/20 | 0.45 |
| ▸ | CA5A | P35218 | 1/20 | 0.45 |
| ▸ | CA7 | P43166 | 1/20 | 0.45 |
| ▸ | CA9 | Q16790 | 1/20 | 0.45 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.45 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.45 |
| ▸ | DNM1 | Q05193 | 4/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.36 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.33 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | HRH2 | P25021 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8850114 | 0.92 | ALDH1A1 (0.50) | MAPTALDH1A1TSHRCA12CA2 | |
| SCHEMBL11713630 | 0.91 | MAPT (0.42) | MAPTALDH1A1TSHRCA12CA2 | |
| SCHEMBL26756027 | 0.91 | MAPT (0.42) | MAPTALDH1A1TSHRCA12CA2 | |
| SCHEMBL3427086 | 0.89 | CA12 (0.61) | MAPTALDH1A1TSHRCA12CA2 | |
| SCHEMBL1408983 | 0.89 | MAPT (0.58) | MAPTALDH1A1TSHRCA12CA2 | |
| SCHEMBL15287 | 0.88 | MAPT (0.44) | MAPTALDH1A1TSHRCA12CA2 | |
| SCHEMBL8368 | 0.88 | — | — | |
| SCHEMBL19206140 | 0.88 | — | — | |
| Water SCHEMBL23012040 | 0.85 | — | — | |
| Hydrochloric Acid SCHEMBL1958786 | 0.85 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240209138-A1 | PRODUCTION OF HARD POLYURETHANE OR POLYISOCYANURATE FOAM | EVONIK OPERATIONS GMBH (DE) | 2024-06-27 | — | — | US | claimed |
| EP-4323420-A1 | PRODUCTION OF HARD POLYURETHANE OR POLYISOCYANURATE FOAM | Evonik Operations GmbH (DE) | 2024-02-21 | — | — | EP | claimed |
| CN-115243789-A | Catalyst composition for polyurethane | 迈图高新材料公司 | 2022-10-25 | — | — | CN | claimed |
| WO-2022218657-A1 | PRODUCTION OF HARD POLYURETHANE OR POLYISOCYANURATE FOAM | EVONIK OPERATIONS GMBH (DE) | 2022-10-20 | — | — | WO | claimed |
| US-20240400793-A1 | COMPOSITION FOR POLYURETHANE FOAM, FOAM PREPARED THEREFROM AND A METHOD THEREOF | MOMENTIVE PERFORMANCE MATERIALS INC. | 2024-12-05 | — | — | US | disclosed |
| CN-118434796-A | Composition for polyurethane foam, foam prepared therefrom and method thereof | 迈图高新材料公司 | 2024-08-02 | — | — | CN | disclosed |
| US-20240209138-A1 | PRODUCTION OF HARD POLYURETHANE OR POLYISOCYANURATE FOAM | EVONIK OPERATIONS GMBH (DE) | 2024-06-27 | — | — | US | disclosed |
| EP-4323420-A1 | PRODUCTION OF HARD POLYURETHANE OR POLYISOCYANURATE FOAM | Evonik Operations GmbH (DE) | 2024-02-21 | — | — | EP | disclosed |
| US-20230338411-A1 | COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS | RECODE THERAPEUTICS, INC. | 2023-10-26 | — | — | US | disclosed |
| US-20230149910-A1 | CATALYST COMPOSITION | MOMENTIVE PERFORMANCE MATERIALS INC. | 2023-05-18 | — | — | US | disclosed |
| US-20230151136-A1 | CATALYST COMPOSITION FOR POLYURETHANES | MOMENTIVE PERFORMANCE MATERIALS INC. | 2023-05-18 | — | — | US | disclosed |
| US-20230151136-A1 | CATALYST COMPOSITION FOR POLYURETHANES | MOMENTIVE PERFORMANCE MATERIALS INC. | 2023-05-18 | — | — | US | disclosed |
| WO-2000055120-A1 | AMIDE DERIVATIVES | ASTRAZENECA AB (SE) | 2000-09-21 | — | — | WO | disclosed |
| WO-2000055153-A1 | AMIDE DERIVATIVES | ASTRAZENECA AB (SE) | 2000-09-21 | — | — | WO | disclosed |
| WO-2000018738-A1 | BENZAMIDE DERIVATIVES AND THEIR USE AS CYTOKINE INHIBITORS | ASTRAZENECA AB (SE) | 2000-04-06 | — | — | WO | disclosed |
| WO-2000007991-A1 | AMIDE DERIVATIVES USEFUL AS INHIBITORS OF THE PRODUCTION OF CYTOKINES | ASTRAZENECA AB (SE) | 2000-02-17 | — | — | WO | disclosed |
| WO-2000007980-A1 | AMIDE DERIVATIVES WHICH ARE USEFUL AS CYTOKINE INHIBITORS | ASTRAZENECA AB (SE) | 2000-02-17 | — | — | WO | disclosed |
| US-4430455-A | N'-(2-Hydroxyalkyl)-N, N, N'-trimethyl-propylene diamines as catalysts for polyurethane foams | ABBOTT LABORATORIES (US) | 1984-02-07 | — | — | US | disclosed |
| US-4048322-A | Bronchially effective xanthene-9-carboxylates | RICHTER GEDEON VEGYESZETI GYAR R.T. (HU) | 1977-09-13 | — | — | US | disclosed |
| US-4044146-A | CHOLINOLYTIC, BRONCHOSPASMOLYTIC | RICHTER GEDEON VEGYESZETI GYAR R.T. (HU) | 1977-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230338411-A1 | COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS | CHMP4B, LIPA, NPC1L1 | MAPT 1993/4885ALDH1A1 4006/4885TSHR 2262/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.